Andreas Rummelt Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

ALXN Quotes by TradingView

Andreas Rummelt is Director of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 28,109 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Andreas Rummelt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 21 2021
SELL
Sale (or disposition) back to the issuer
-
28,109 Reduced 100.0%
0 Common Stock, par valu...
May 20 2021
BUY
Grant, award, or other acquisition
-
2,495 Added 8.15%
28,109 Common Stock, par valu...
AR

Andreas Rummelt

Director
Boston, MA

Track Institutional and Insider Activities on ALXN

Follow ALEXION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALXN